Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05080166

UPLYFT For Lymphoma Survivors

An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

Detailed description

This is a two phase pilot study to develop and pilot the UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) program intervention that includes lymphoma survivorship information and acceptance and commitment therapy strategies to alleviate fear of cancer recurrence, reduce distress, and improve quality of life among lymphoma survivors. Phase 1 will be a two-part development process of the UPLYFT program based on interview feedback from lymphoma and mental health clinicians and then feedback from a six-person group of lymphoma survivors after participation in an UPLYFT program field test. Phase 2 is a randomized pilot study using the UPLFYT program finalized in Phase 1. Research procedures include: * In depth interview (lymphoma and mental health clinicians) * Screening for eligibility * 6 weekly intervention sessions (lymphoma survivors) * Baseline Assessments and Questionnaires (lymphoma survivors) 74 people are expected to participate in this study with 14 in Phase 1 and 60 in Phase 2. The American Society of Hematology is providing funding for the trial.

Conditions

Interventions

TypeNameDescription
OTHERInterview with CliniciansOne time, qualitative interview of clinicians for feedback on UPLYFT intervention
OTHERField Test of UPLYFT with Lymphoma Survivors6 session of UPLYFT intervention with Lymphoma Survivors for feedback
BEHAVIORALPilot of UPLYFT with Lymphoma Survivors6 session of UPLYFT intervention with Lymphoma Survivors

Timeline

Start date
2022-02-08
Primary completion
2026-05-31
Completion
2026-08-31
First posted
2021-10-15
Last updated
2026-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05080166. Inclusion in this directory is not an endorsement.